Caxton Corp has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $15.8 Million distributed in 15 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Xeris Biopharma Holdings, Inc. with a value of $6.83M, Rezolute, Inc. with a value of $6.29M, Spdr S&P 500 ETF Trust with a value of $1.65M, Berkshire Hathaway Inc Class B with a value of $513K, and Spdr Gold Trust with a value of $283K.

Examining the 13F form we can see an decrease of $7.51M in the current position value, from $23.3M to 15.8M.

Caxton Corp is based out at Princeton, NJ

Below you can find more details about Caxton Corp portfolio as well as his latest detailed transactions.

Portfolio value $15.8 Million
Healthcare: $13.3 Million
ETFs: $1.94 Million
Financial Services: $513,000

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 15
  • Current Value $15.8 Million
  • Prior Value $23.3 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 4 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Caxton Corp Portfolio

Follow Caxton Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Corp, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Corp with notifications on news.